Company: MDCXW
Filing Date: 2025-08-12
Form Type: 253G2
Source: 0001062993-25-014090
Chunk: 38

Company: Medicus Pharma Ltd.
Filing Date: 2025-08-12
Form: 253G2
Chunk 38
---
 are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

<div align='center'>25</div>

| No.      
 2.1      |     | Description of Exhibit                                                                                                                                                                                                                                                                             
 Share Exchange Agreement, dated June 29, 2025, by and between Medicus Pharma Ltd., Antev Limited and each of the securityholders of Antev Limited party thereto. (incorporated by reference from Exhibit 2.1 to the Registrant's Current Report on Form 8-K/A, filed with the SEC on July 3, 2025) |
|:---------|:----|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 3.1*     |     | Bylaws of Medicus Pharma Ltd., as in effect as of the date hereof                                                                                                                                                                                                                                  |
| 3.2*     |     | Articles of Amendment of Medicus Pharma Ltd., effective as of August 8, 2025.                                                                                                                                                                                                                      |
| 4.1      |     | Form of Debenture (incorporated herein by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K, filed on May 5, 2025)                                                                                                                                                              |
| 4.2      |     | Form of Subscription Agreement (incorporated by reference from Exhibit 4.8 to the Company's Registration Statement on Form S-1, filed with the SEC on May 27, 2025)                                                                                                                                |
| 4.3      |     | Common Share Purchase Warrant (incorporated herein by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K, filed on June 2, 2025)                                                                                                                                                 |
| 4.4      |     | Warrant Agency Agreement, dated as of June 2, 2025, by and between Medicus Pharma Ltd. and Odyssey Transfer and Trust Company, as warrant agent (incorporated herein by reference to Exhibit 4.3 to the Company's Current Report on Form 8-K, filed on June 2, 2025)                               |
| 10.1     |     | Securities Purchase Agreement, by and between Medicus Pharma Ltd. and YA II PN, Ltd., dated May 2, 2025 (incorporated herein by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, filed on May 5, 2025